Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

NASDAQ:SNBR - Nasdaq - US83125X1037 - Common Stock - Currency: USD

11.425  +0.29 (+2.65%)

Fundamental Rating

2

Overall SNBR gets a fundamental rating of 2 out of 10. We evaluated SNBR against 124 industry peers in the Specialty Retail industry. SNBR has a bad profitability rating. Also its financial health evaluation is rather negative. SNBR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SNBR had negative earnings in the past year.
In the past year SNBR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: SNBR reported negative net income in multiple years.
Of the past 5 years SNBR 4 years had a positive operating cash flow.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

SNBR has a worse Return On Assets (-5.15%) than 67.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.59%, SNBR is in line with its industry, outperforming 56.45% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SNBR is below the industry average of 11.79%.
Industry RankSector Rank
ROA -5.15%
ROE N/A
ROIC 4.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

SNBR has a Operating Margin (1.77%) which is in line with its industry peers.
In the last couple of years the Operating Margin of SNBR has declined.
SNBR has a Gross Margin of 60.30%. This is amongst the best in the industry. SNBR outperforms 89.52% of its industry peers.
In the last couple of years the Gross Margin of SNBR has remained more or less at the same level.
Industry RankSector Rank
OM 1.77%
PM (TTM) N/A
GM 60.3%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

0

2. Health

2.1 Basic Checks

SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SNBR has been increased compared to 1 year ago.
The number of shares outstanding for SNBR has been reduced compared to 5 years ago.
SNBR has a worse debt/assets ratio than last year.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of 0.15. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
SNBR has a Altman-Z score of 0.15. This is amonst the worse of the industry: SNBR underperforms 81.45% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACC0.48
WACC9.53%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

SNBR has a Current Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR has a Current ratio of 0.19. This is amonst the worse of the industry: SNBR underperforms 96.77% of its industry peers.
A Quick Ratio of 0.08 indicates that SNBR may have some problems paying its short term obligations.
SNBR has a Quick ratio of 0.08. This is amonst the worse of the industry: SNBR underperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.08
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

1

3. Growth

3.1 Past

SNBR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.82%.
Looking at the last year, SNBR shows a very negative growth in Revenue. The Revenue has decreased by -14.39% in the last year.
SNBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.19% yearly.
EPS 1Y (TTM)-2.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-395.45%
Revenue 1Y (TTM)-14.39%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.71%

3.2 Future

Based on estimates for the next years, SNBR will show a very strong growth in Earnings Per Share. The EPS will grow by 34.93% on average per year.
SNBR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.66% yearly.
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y34.93%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.66%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

SNBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 30.07, the valuation of SNBR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as SNBR.
SNBR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.29.
Industry RankSector Rank
PE N/A
Fwd PE 30.07
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNBR is valued cheaply inside the industry as 95.16% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.84
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SNBR's earnings are expected to grow with 42.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.63%
EPS Next 3Y42.99%

More info and screens

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SLEEP NUMBER CORP

NASDAQ:SNBR (8/18/2025, 3:23:51 PM)

11.425

+0.29 (+2.65%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-28 2025-10-28/amc
Inst Owners79.59%
Inst Owner Change8.27%
Ins Owners6.74%
Ins Owner Change32.83%
Market Cap258.89M
Analysts48.89
Price Target7.65 (-33.04%)
Short Float %29.45%
Short Ratio9.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1173.18%
Min EPS beat(2)-1452.29%
Max EPS beat(2)-894.07%
EPS beat(4)2
Avg EPS beat(4)-579.79%
Min EPS beat(4)-1452.29%
Max EPS beat(4)18.3%
EPS beat(8)3
Avg EPS beat(8)-313.28%
EPS beat(12)6
Avg EPS beat(12)-155.64%
EPS beat(16)8
Avg EPS beat(16)-113.44%
Revenue beat(2)0
Avg Revenue beat(2)-6.58%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-3.11%
Revenue beat(4)0
Avg Revenue beat(4)-6.15%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-5.03%
Revenue beat(12)2
Avg Revenue beat(12)-4.12%
Revenue beat(16)4
Avg Revenue beat(16)-3.45%
PT rev (1m)15.38%
PT rev (3m)-10%
EPS NQ rev (1m)56.76%
EPS NQ rev (3m)70.59%
EPS NY rev (1m)0%
EPS NY rev (3m)19.9%
Revenue NQ rev (1m)-5.38%
Revenue NQ rev (3m)-14.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.07
P/S 0.17
P/FCF N/A
P/OCF 53.7
P/B N/A
P/tB N/A
EV/EBITDA 2.84
EPS(TTM)-1.82
EYN/A
EPS(NY)0.38
Fwd EY3.33%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.21
OCFY1.86%
SpS67.28
BVpS-21.21
TBVpS-24.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.15%
ROE N/A
ROCE -27.38%
ROIC 4.59%
ROICexc 4.6%
ROICexgc 5.37%
OM 1.77%
PM (TTM) N/A
GM 60.3%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexcg growth 3Y-45.92%
ROICexcg growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score5
Asset Turnover1.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.39
Cap/Depr 28.53%
Cap/Sales 1.15%
Interest Coverage 250
Cash Conversion 5.46%
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.08
Altman-Z 0.15
F-Score5
WACC9.53%
ROIC/WACC0.48
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-395.45%
EPS Next Y56.65%
EPS Next 2Y55.63%
EPS Next 3Y42.99%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-14.39%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.71%
Revenue Next Year-10.58%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.84%
Revenue Next 5Y-2.66%
EBIT growth 1Y5.54%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year288.61%
EBIT Next 3Y62.73%
EBIT Next 5Y48.32%
FCF growth 1Y65.5%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-81.53%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%